Biofilms of S. aureus accumulate cells resistant to the antibiotic rifampicin. We show here that the accumulation of rifampicin resistant mutants (RifR) in biofilms is not equable but rather is a local event, suggesting that the growth of a few locally emerged mutants is responsible for this. Competition assays demonstrated that, compared to wild-type bacteria, the isolated RifR mutants have a growth advantage in biofilms, but not in planktonic culture. To gain insight into the mechanism of the growth advantage, we tested the involvement of the two-component systems (TCS) that sense and respond to environmental changes. We found that a deletion of SrrAB or NreBC has a drastic effect on the growth advantage of RifR mutants, suggesting the im...
The complex spatial structure and the heterogeneity within biofilms lead to the emergence of specifi...
It is possible for a variety of bacteria, including pathogens, to form biofilms, which serve as a me...
The glycopeptide vancomycin is commonly used to treat a variety of bacterial infections, especially ...
Biofilms of S. aureus accumulate cells resistant to the antibiotic rifampicin. We show here that the...
Biofilms of S. aureus accumulate cells resistant to the antibiotic rifampicin. We show here that the...
Biofilms of S. aureus accumulate cells resistant to the antibiotic rifampicin. We show here that the...
To investigate the development of mutational resistance to antibiotics in staphylococcal biofilms.Mu...
Objectives: To investigate the development of mutational resistance to antibiotics in staphylococcal...
OBJECTIVES: To investigate the development of mutational resistance to antibiotics in staphylococcal...
Abstract Staphylococcus aureus is one of the most common pathogens in biofilm-associated chronic inf...
The complex spatial structure and the heterogeneity within biofilms lead to the emergence of specifi...
The complex spatial structure and the heterogeneity within biofilms lead to the emergence of specifi...
Objectives: To investigate in vivo fitness of rifampicin-resistant Staphylococcus aureus mutants in ...
The complex spatial structure and the heterogeneity within biofilms lead to the emergence of specifi...
The complex spatial structure and the heterogeneity within biofilms lead to the emergence of specifi...
The complex spatial structure and the heterogeneity within biofilms lead to the emergence of specifi...
It is possible for a variety of bacteria, including pathogens, to form biofilms, which serve as a me...
The glycopeptide vancomycin is commonly used to treat a variety of bacterial infections, especially ...
Biofilms of S. aureus accumulate cells resistant to the antibiotic rifampicin. We show here that the...
Biofilms of S. aureus accumulate cells resistant to the antibiotic rifampicin. We show here that the...
Biofilms of S. aureus accumulate cells resistant to the antibiotic rifampicin. We show here that the...
To investigate the development of mutational resistance to antibiotics in staphylococcal biofilms.Mu...
Objectives: To investigate the development of mutational resistance to antibiotics in staphylococcal...
OBJECTIVES: To investigate the development of mutational resistance to antibiotics in staphylococcal...
Abstract Staphylococcus aureus is one of the most common pathogens in biofilm-associated chronic inf...
The complex spatial structure and the heterogeneity within biofilms lead to the emergence of specifi...
The complex spatial structure and the heterogeneity within biofilms lead to the emergence of specifi...
Objectives: To investigate in vivo fitness of rifampicin-resistant Staphylococcus aureus mutants in ...
The complex spatial structure and the heterogeneity within biofilms lead to the emergence of specifi...
The complex spatial structure and the heterogeneity within biofilms lead to the emergence of specifi...
The complex spatial structure and the heterogeneity within biofilms lead to the emergence of specifi...
It is possible for a variety of bacteria, including pathogens, to form biofilms, which serve as a me...
The glycopeptide vancomycin is commonly used to treat a variety of bacterial infections, especially ...